Digital AI in Drug Discovery: Day One There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector.
Digital The next chapter for AI protein structure prediction When Alphabet announced in 2021 that its AlphaFold AI could predict the structure of almost
News ESC: MSD/Bayer's Verquvo disappoints in heart failure trial Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
